Prasad, B., Jafari, M., Toppings, J., Gross, L., Kappel, J., & Au, F. (2020). Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients. Can J Kidney Health Dis.
Chicago ZitierstilPrasad, Bhanu, Maryam Jafari, Julie Toppings, Linda Gross, Joanne Kappel, und Flora Au. "Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients." Can J Kidney Health Dis 2020.
MLA ZitierstilPrasad, Bhanu, et al. "Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients." Can J Kidney Health Dis 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.